The modulation of intra-articular inflammation, cartilage matrix and bone loss in mono-articular arthritis induced by heat-killed Myobacterium tuberculosis

Inflammopharmacology

Volumn 12, Issue 5-6, 2005, Pages 551-567

  Seed, M P ^a   Gardner, C R ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITÉ DE ROUEN   (France)

Author keywords

Antirheumatic drugs; Arthritis; Bone; Cartilage; Inflammation; Mycobacterium tuberculosis; Non steroidal anti inflammatory

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; AZATHIOPRINE; CYCLOSPORIN A; DEXAMETHASONE; DICLOFENAC; LEVAMISOLE; METHOTREXATE; NAPROXEN; PIROXICAM; PREDNISOLONE; ROMAZERIT; TENEDAP; TIAPROFENIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTHRITIS; ARTICLE; BONE DEFECT; CARTILAGE MATRIX; CONTROLLED STUDY; DRUG MECHANISM; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OSTEOLYSIS; PATELLA; PRIORITY JOURNAL; RAT; RAT STRAIN;

EID: 27744572201     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1163/156856005774382607     Document Type: Article

References (66)

1. Bark, K. H., Lee, W. P., Diehl, L. J., Ross, J., Gribling, P., Zhang, Y., Nguyen, K., van Bruggen, N., Hurst, S. and Carano, R. A. (2004). Quantification of bone loss and repair for therapeutic evaluation in collagen-induced arthritis, by micro-computed tomography and automated image analysis, Arthritis Rheum. 50, 3377-3386.
2. Barthold, P. M., Shelley, H. and Vernon-Roberts B. (1989). Effect of cyclosporin A on connective tissue deposition in experimental inflammatory lesions, Matrix 9, 293-300.
3. Billingham, M. E. J. (1990). Models of arthritis and the search for anti-arthritic drugs, in: Antirheumatic Drugs, Orme, M. C. E. (Ed.), pp. 1-47. Pergamon Press, New York, NY.
4. Bloxham, D. P., Bradshaw, D., Cashin, C. H., Dodge, B. B., Lewis, E. J., Westmacott, D. and Self, C. R. (1990). Biologic properties of Romazerit (Ro 31-3948), a potential disease modifying anti-rheumatic drug, J. Pharmacol. Exp. Ther. 252, 1331-1340.
5. Borel, J. F., Feurer, C., Magneé, C. and Stähelin H. (1972). Effects of the new anti-lymphocytic peptide cyclosporin A in animals, Immunology 32, 1017-1025.
6. Borel, J. F., Wiesenger, D. and Gubler, H. U. (1978). Effects of anti-lymphocytic agent Cyclosporin A in chronic inflammation, Eur. J. Rheumatol Inflamm. 1, 237-241.
7. Borel, J. F., Gubler, H. U., Hiestand, P. C. and Wenger, R. M. (1986). Immunological properties of cyclosporin (Sandimmun-R) and (val2)dihydro- cyclosporin and their prospect in chronic inflammation, Adv. Inflamm. Res. 11, 277-291.
8. Bottomley, K. M. K., Griffiths, R. J., Rising, T. G. and Steward, A. (1988). A modified air pouch model for evaluating the effects of compounds on granuloma-induced cartilage degradation, Br. J. Pharmacol. 93, 627-635.
9. Brandt, K. (1987). Effects of non-steroidal anti-inflammatory drugs on chondrocyte metabolism in vitro and in vivo, Am. J. Med. 83 (Suppl. 5a), 29-34.
10. Clay, K., Seed, M. P. and Clements-Jewery, S. (1989). Studies on interleukin-1β induced glycosaminoglycan release from rat femoral head cartilage in vitro, J. Pharm. Pharmacol. 41, 503-504.
11. 1α on osteoclast formation in mouse bone marrow cultures, J. Bone Miner. Res. 6, 157-164.
12. Colville-Nash, P. R., Alam, C. A. S., Appleton, I., Brown, J. R., Seed, M. P. and Willoughby, D. A. (1995). The pharmacological modulation of angiogenesis in chronic granulomatous inflammation, J. Pharm. Exp. Ther. 274, 1463-1472.
13. Crossley, M. J. and Hunneyball, I. M. (1983). Studies on the release of proteolytic enzymes during synovium-induced cartilage breakdown in vitro and the action of anti-inflammatory drugs, Biochem. Pharmacol. 33, 1263-1271.
14. Del Pozo, E., Graeber, M., Elford, P. and Payne, T. (1990). Regression of bone and cartilage loss in adjuvant arthritic rats after treatment with cyclosporin A, Arthritis Rheum. 33, 247-252.
15. Dingle, J. T. (1991). Cartilage maintenance in osteoarthritis: interaction of cytokine, NSAIDs and prostaglandins in cartilage repair, J. Rheumatol. 18 (Suppl. 28), 30-37.
16. Dingle, J. T. (1992). The role of cytokines and NSAIDs in osteoarthritis: the use of human cartilage in drug assessment, Eur. J. Rheum. Inflamm. 12, 3-8.
17. Dingle, J. T. and Shield, M. J. (1990). The interactions of cytokines, NSAIDs and prostaglandins in cartilage destruction and repair, Adv. Prostaglandin Thromboxane Leukotr. Res. 21, 955-966.
18. DiRosa, M., Giroud, J. P. and Willoughby, D. A. (1971). Studies of the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine, J. Pathol. 104, 15-29.
19. Ehrenstein, M., Isenberg, D. and Seed, M. P. (1996). Endogenous mediators of pain and inflammation, in: Pharmacology in the practice of anaesthesia, Kaufman, L. and Taberner, P. V. (Eds), pp. 385-415. Edward Arnold, London.
20. Farndale, R. W., Buttle, D. J. and Barrett, A. J. (1986). An Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue, Biochim. Biophys. Acta 883, 173-177.
21. Garrett, I. R., Whitehouse, M. W., Vernon-Roberts, B. and Brooks, P. M. (1985). Ambivalent properties of gold drugs in adjuvant induced polyarthritis in rats, J. Rheumatol. 12, 1079-1082.
22. Gilroy, D., Tomlinson, A., Greenslade, K., Seed, M. P. and Willoughby, D. A. (1998). The effects of cyclooxygenase-2 inhibitors on cartilage erosion and bone loss in a model of mycobacterium tuberculosis-induced monoarticular arthritis in the rat, Inflammation 22, 509-519.
23. Goodwin, J. S., Bankhurst, A. D. and Messner, R. P. (1977). Suppression of human T cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell, J. Exp. Med. 146, 1719-1734.
24. Haynes, D. R., Garrett, I. R., Whitehouse, M. W. and Vernon-Roberts, B. (1988). Do gold drugs inhibit interleukin-1? Evidence from an in vitro lymphocyte activating factor assay, J. Rheumatol. 15, 775-778.
25. Higgs, G. A., Moncada, S. and Vane, J. R. (1984). Eicosanoids in inflammation, Ann. Clin. Res. 16, 287-299.
26. Hunneyball, I. M., Crossley, M. J. and Spowage, M. (1986). Pharmacological studies of antigen induced arthritis in BALB/c mice I. Characterisation of the arthritis and the effects of steroidal and non-steroidal anti-inflammatory drugs, Agents Actions 18, 384-393.
27. Huskisson, E. C., Berry, H., Gishen, P., Jubb, R. W. and Whitehead, J. (1995). Effects of antiinflammatory drugs on the progression of osteoarthritis of the knee. LINK Study Group. Longitudinal Investigation of Nonsteroidal Antiinflammatory Drugs in Knee Osteoarthritis, J. Rheumatol. 22, 1941-1946.
28. Ingemann-Nielsen, M., Halsov, O., Hansen, T. M., Halberg, P., Stage, P. and Loenzen, I. (1983). Clinical synovitis and radiological lesions in rheumatoid arthritis, Scand. J. Rheumatol. 12, 237-240.
29. Iwata, H. (1987). Effect of anti-arthritic drugs for articular cartilage and synovial fluid, New Trends Rheumatol. 5, 35-46.
30. Kunkle, S. L., Chensueq, S. W. and Phan, S. H. (1983). Prostaglandins as endogenous mediators of interleukin-1 production, J. Immunol. 136, 186-192.
31. Lange, F., Bajtner, E., Rintisch, C., Nandakumar, K. S., Sack, U. and Holmdahl, R. (2005). Methotrexate ameliorates T cell dependent auto-immune arthritis and encephalomyelitis but not antibody or fibroblast induced arthritis, Ann. Rheum. Dis. 64, 599-605.
32. Ledbetter, D. J., Reidy, M. A. and Tapper D. (1988). Cyclosporin causes endothelial cell injury, a mechanism for vascular complications after transplantation, Am. Coll. Surg. Clin. Congr. Surg. Forum 39, 268-269.
33. Lewis, G. P. and Barrett, M. L. (1987). Immunosuppressive actions of prostaglandins and the possible increase in chronic inflammation after cyclo-oxygenase inhibitors, Agents Actions 19, 59-65.
34. Luukkainen, R., Kaarela, K., Isomaki, H. and Kiviniemi P. (1983). Relationship between clinical synovitis and radiological destruction in rheumatoid arthritis, Clin. Rheumatol. 2, 223-226.
35. Mankin, H. J. and Conger, K. A. (1966). The acute effects of intra-articular hydrocortisone on articular cartilage in rabbits, J. Bone Jt. Surg. 48A, 1383-1388.
36. Mitchell, J. A., Akarasereenont, P., Thiermermann, C., Flower, R. J. and Vane, J. R. (1993). Selectivity of non-steroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclo-oxygenase, Proc. Natl Acad Sci USA 90, 11693-11697.
37. Moilanen, E., Alanko, J., Asmawi, M. Z. and Vapaatalo, H. (1988). CP-66,248, a new anti-inflammatory agent, is a potent inhibitor of leukotriene-B4 and prostanoid synthesis in human polymorphonuclear leucocytes in vitro, Eicosanoids 1, 35-39.
38. Ormorod, D. J., Cawley, S. and Miller, T. E. (1990). Cyclosporin A modulation of the acute inflammatory response: an explanation for the effect of CSA on host defences in infection, J. Exp. Pathol. 71, 69-82.
39. Otterness, I. G., Caty, T. J. and Loose, L. D. (1989). Tenidap: a new drug of arthritis, in: Approaches to inflammatory diseases, Lewis, A. J., Doherty, N. J. and Ackermann, N. R. (Eds), pp. 229-241. Elsevier, Amsterdam.
40. Palmoski, M. J. and Brandt, K. D. (1983a). In vivo effect of aspirin on canine osteoarthritic cartilage, Arthritis Rheum. 26, 994-1001.
41. Palmoski, M. J. and Brandt, K. D. (1983b). Relationship between the matrix proteoglycan content and the effects of salicylate and indomethacin on articular cartilage, Arthritis Rheum. 26, 528-531.
42. Pettipher, E. R., Henderson, B., Hardingham, T. and Ratcliffe, A. (1989a). Cartilage proteoglycan depletion in acute and chronic antigen-induced arthritis, Arthritis Rheum. 32, 601-607.
43. Pettipher, E. R., Henderson, B., Edwards, J. C. W. and Higgs, G. A. (1989b). Effect of indomethacin on swelling, lymphocyte influx, and cartilage GAG depletion in experimental arthritis, Ann. Rheum. Dis. 48, 623-627.
44. Pigatton, P. D., Mozzanica, N., Polenghi, M. M., Altomare, G. F. and Finzi, A. F. (1988). Cyclosporin A inhibits polymorphonuclear leucocyte chemotaxis in vivo, Transplant. Proc. 20 (Suppl. 4), 91-94.
45. Probert, A. W., Schrier, D. J. and Gilbertstein, R. B. (1984). Effects of antiarthritic compounds on type II collagen-induced arthritis in rats, Arch. Int. Pharmacodyn. Ther. 269, 167-176.
46. Rainsford, K. D. (1987). Effects of anti-inflammatory drugs on the release from porcine synovial tissue in vitro of interleukin-1 like cartilage degrading like activity, Agents Actions 21, 337-340.
47. Rashad, S. L., Revell, P., Hemingway, A., Low, F., Rainsford, K. D. and Walker, F. (1989). The effect of non-steroidal anti-inflammatory drugs on the course of osteoarthritis, Lancet ii, 519-522.
48. Reid, I. R. (1989). Steroid osteoporosis, Calcif. Tissue Int. 45, 63-67.
49. Russell, R. G., Graveley, R. and Skjodt, H. (1993). The effects of cyclosporin A on bone and cartilage, Br. J. Rheumatol. 32 (Suppl. 1), 42-46.
50. Seed, M. P. (2003). The assessment of inflammation, cartilage matrix and bone loss in experimental mono-articular arthritis in the rat, Methods Mol. Biol. 225, 161-174.
51. Seed, M. P., Hambleton, P. H., Bowden, A. R., Clements-Jewery, S. and Gardner, C. R. (1993). Rapid quantitation of joint destruction in irritant mono-articular arthritis induced by heat-killed Mycobacterium tuberculosis, Eur. J. Rheum. Inflamm. 13, 27-33.
52. Seitz, M., Valbracht, J., Quach, J. and Lotz, M. (2003). Gold sodium thiomalate and chloroquine inhibit cytokine production in monocytic THP-1 cells through distinct transcriptional and posttranslational mechanisms, J. Clin. Immunol. 23, 477-484.
53. Shepeard, H., Pilsworth, L. M. C., Hazelman, B. and Dingle, J. T. (1982). Effects of anti-rheumatic drugs on the production and action of porcine catabolin, Ann. Rheum. Dis. 41, 463-468.
54. Shinmei, M., Shimada, K., Shinego, Y., Kikuchi, K., Miyzaki, K. and Shimomura, Y. (1985). Effects of anti-inflammatory drugs on proteoglycan synthesis and degradation in rabbit articular chondrocytes in vitro, Proc. XVI Int. Congr. Rheumatol. (Excerpta Medica), pp. 59-68.
55. Smith, J. B. and Willis, A. L. (1971). Aspirin selectively inhibits prostaglandin production in human platelets, Nature 231, 235-237.
56. Smith, R. J. and Sly, L. M. (1996). Type-II collagen-induced arthritis in the diabetic-resistant biobreeding rat: inflammatory and histopathological features of joint pathology and effects of anti-inflammatory and anti-rheumatic drugs on this chronic arthritic process, J. Pharm. Exp. Ther. 277, 1801-1813.
57. Stewart, P. J. and Stern, P. H. (1989). Cyclosporins: correlation of immunosuppressive activity and inhibition of bone resorption, Calcif. Tiss. Int. 45, 222-256.
58. Tashjian, A. H., Voekel, E. F., Lazzaro, M., Goad, D., Bosma, T. and Levine, L. (1987). Tumour necrosis factor-α (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism, Endocrinology 120, 2029-2036.
59. Thomson, A. W., Whiting, P. H. and Simpson, J. T. (1984). Cyclosporine: immunology, toxicity, and pharmacology in experimental animals, Agents Actions 15, 3-4.
60. Vane, J. R. (1971). Inhibition of prostaglandin synthesis as a possible mechanism of action for aspirin-like drugs. Nature 231, 232-235.
61. Warner, T. D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J. A. and Vane, J. R. (1999). Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis, Proc. Natl. Acad. Sci. USA 96, 7563-7568.
62. Erratum in Proc. Natl. Acad. Sci. USA 96, 9666 (1999).
63. Whitehouse, M. W., Horewood, A. H. and Vernon-Roberts, B. (1988). Variable responses to gold (I)-thiolates (chrysotherapy) in two models of rat polyarthritis, Agents Actions 24 (Suppl.), 184-188.
64. Williams, T. J. and Peck, M. J. (1977). Role of prostaglandin mediated vasodilatation in inflammation, Nature 270, 530-532.
65. Young, A., Corbett, M. and Brook, A. (1980). The clinical assessment of joint inflammatory activity in rheumatoid arthritis related to radiological progression, Rheumatol. Rehabil. 19, 14-19.
66. Zenke, G., Baumann, G., Wenger, R., Hiestand, P., Quesniaux, V. and Andersen, E. (1993). Molecular mechanisms of immunosuppression by cyclosporins, Ann. N.Y. Acad. Sci. 685, 330-335.